Positions
- Associate Professor of Surgery
-
Division of Surgical Oncology
Baylor College of Medicine
- Associate Director for Core Medical Students
-
Department of Surgery
- Central Medical Director for the OR
-
Ben Taub Hospital
Addresses
- Ben Taub Hospital (Hospital)
-
1504 Taub Loop
Houston, TX, 77030
United States
Education
- BS from University of Michigan
- 04/1995 - Ann Arbor, Michigan, United States
- Cellular and Molecular Biology
- MD from Temple University School of Medicine
- 05/2001 - Philadelphia, Pennsylvania, United States
- Residency at UCLA Medical Center
- 06/2009 - Los Angeles, California, United States
- Clinical Fellowship at Surgery Branch of the National Cancer Institute
- 06/2006 - Bethesda, Maryland, United States
- Fellowship at The University of Texas MD Anderson Cancer Center
- 06/2011 - Houston, United States
Certifications
- #054486, 10/2009
- American Board of Surgery
Honors & Awards
- STAR Faculty Award for Excellence in Patient Care
- Baylor College of Medicine
- Norton Rose Fulbright Faculty Excellence Award for Teaching & Evaluation
- Baylor College of Medicine
- Professional Educator Appreciation and Recognition (PEAR) Award
- Baylor College of Medicine
Professional Interests
- Surgical Oncology
Professional Statement
Cary Hsu, M.D., assistant professor of Surgery, is a surgical oncologist at Ben Taub Hospital and committed to caring for underserved patients in Houston.
Dr. Hsu earned a degree in Cellular and Molecular Biology at the University of Michigan and completed medical school at Temple University School of Medicine. He completed his residency at UCLA and a clinical fellowship at the National Cancer Institute. Dr. Hsu received fellowship training in surgical oncology at MD Anderson Cancer Center.
Dr. Hsu's clinical interest is in the multidisciplinary management of solid tumors. The multidisciplinary team at Ben Taub is committed to providing evidence-based, state of the art care for all cancer patients. Dr. Hsu is also engaged in the training of students and residents at the Baylor College of Medicine. Dr. Hsu's research interests include clinical outcomes in surgical oncology and cancer immunotherapy.
Dr. Hsu earned a degree in Cellular and Molecular Biology at the University of Michigan and completed medical school at Temple University School of Medicine. He completed his residency at UCLA and a clinical fellowship at the National Cancer Institute. Dr. Hsu received fellowship training in surgical oncology at MD Anderson Cancer Center.
Dr. Hsu's clinical interest is in the multidisciplinary management of solid tumors. The multidisciplinary team at Ben Taub is committed to providing evidence-based, state of the art care for all cancer patients. Dr. Hsu is also engaged in the training of students and residents at the Baylor College of Medicine. Dr. Hsu's research interests include clinical outcomes in surgical oncology and cancer immunotherapy.
Selected Publications
-
1. Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, Erogul J, Hsu C, Dunlop C, La Du BN. " Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R " ;
Pubmed PMID: 9763535. -
2. Sorenson RC, Bisgaier CL, Aviram M, Hsu C, Billecke SS, and La Du BN. " Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase/arylesterase " ;
Pubmed PMID: 10421458. -
3. Doorn JA, Sorenson RC, Billecke SS, Hsu C, and La Du BN. " Evidence that several conserved histidine residues are required for hydrolytic activity of human paraoxonase/arylesterase " ;
Pubmed PMID: 10421457. -
4. Sorenson RC, Bisgaier CL, Aviram M, Hsu C, Billecke S, and La Du BN. " Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity " ;
Pubmed PMID: 10479665.
Log In to edit your profile